S. Nogué Toxicology Department, Hospital Clinic, Barcelona, Spain A 21-year-old woman presented to the emergency department 8 h after the ingestion of 5,100 mg of ferrous sulfate (110 mg/kg) in a suicide attempt.
At admission she was hemodynamically stable without pathologic findings at examination. Laboratory tests showed a mild decrease in prothrombin time and a compensated metabolic acidosis with normal renal function and liver enzymes. An abdominal x-ray showed normal findings without visible radiopaque pills.
Initial serum iron levels were 300 lg/dL. The patient was transferred to the intensive care unit for monitoring. Chelation therapy with deferoxamine was then started at 15 mg/kg/24 h and the patient's urine turned a redorange color after starting this treatment (Fig. 1) . After 24 h of treatment serum iron levels decreased to 87 lg/dL and chelation therapy was withdrawn. The patient remained clinically stable with no medical complications. She was discharged from hospital 5 days after admission.
Deferoxamine is a specific iron chelator that binds ferric iron forming a water-soluble compound that is rapidly excreted by the kidney, causing a vin rosé discoloration to the urine. It is considered the drug of choice for the treatment of significant iron intoxication. Change in urine color may confirm the effectiveness of this antidote.
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